Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire Falandry

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Current Oncology Reports|June 14, 2018
Toxicity of Cancer Therapies in Older PatientsOlivia Le Saux, Claire Falandry
Current Oncology Reports|February 8, 2018
Is There an Age Threshold for Holding Off on Testing Novel Therapies?Olivia Le Saux, Claire Falandry
Journal of the American Geriatrics Society|April 10, 2023
Cell cycle arrest: A breakthrough in the supportive care of older cancer patientsClaire Falandry, Alan List, Lodovico Balducci
Pharmacogenomics|September 17, 2011
Revisiting the frontiers of pharmacogenomics of colon cancerClaire Falandry, Marc Bonnefoy, Gilles Freyer
Journal of Geriatric Oncology|November 17, 2023
Senotherapy, cancer, and agingLodovico Balducci, Claire Falandry, Silvio Monfardini
Soins. Gerontologie|February 16, 2019
[Prehabilitation, therapeutic innovation]Claire Falandry, Christine Ravot, Vincent Collange
Current Oncology Reports|August 20, 2022
New Advances in Supportive Care: Chemoprotective Agents as Novel Opportunities in Geriatric OncologyLodovico Balducci, Claire Falandry, Alan List
Current Oncology Reports|May 25, 2015
The biology of aging and lymphoma: a complex interplayClémentine Sarkozy, Gilles Salles, Claire Falandry
Current Oncology Reports|November 3, 2022
Correction to: New Advances in Supportive Care: Chemoprotective Agents as Novel Opportunities in Geriatric OncologyLodovico Balducci, Claire Falandry, Alan List
Drugs & Aging|January 30, 2023
A Proactive Approach to Prevent Hematopoietic Exhaustion During Cancer Chemotherapy in Older Patients: Temporary Cell-Cycle ArrestLodovico Balducci, Claire Falandry, Alan List
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Current Oncology Reports|June 14, 2018
Toxicity of Cancer Therapies in Older PatientsOlivia Le Saux, Claire Falandry
Current Oncology Reports|February 8, 2018
Is There an Age Threshold for Holding Off on Testing Novel Therapies?Olivia Le Saux, Claire Falandry
Journal of the American Geriatrics Society|April 10, 2023
Cell cycle arrest: A breakthrough in the supportive care of older cancer patientsClaire Falandry, Alan List, Lodovico Balducci
Pharmacogenomics|September 17, 2011
Revisiting the frontiers of pharmacogenomics of colon cancerClaire Falandry, Marc Bonnefoy, Gilles Freyer
Journal of Geriatric Oncology|November 17, 2023
Senotherapy, cancer, and agingLodovico Balducci, Claire Falandry, Silvio Monfardini
Soins. Gerontologie|February 16, 2019
[Prehabilitation, therapeutic innovation]Claire Falandry, Christine Ravot, Vincent Collange
Current Oncology Reports|August 20, 2022
New Advances in Supportive Care: Chemoprotective Agents as Novel Opportunities in Geriatric OncologyLodovico Balducci, Claire Falandry, Alan List
Current Oncology Reports|May 25, 2015
The biology of aging and lymphoma: a complex interplayClémentine Sarkozy, Gilles Salles, Claire Falandry
Current Oncology Reports|November 3, 2022
Correction to: New Advances in Supportive Care: Chemoprotective Agents as Novel Opportunities in Geriatric OncologyLodovico Balducci, Claire Falandry, Alan List
Drugs & Aging|January 30, 2023
A Proactive Approach to Prevent Hematopoietic Exhaustion During Cancer Chemotherapy in Older Patients: Temporary Cell-Cycle ArrestLodovico Balducci, Claire Falandry, Alan List
Pageof 10